cancerGRACE
GRACEcast - Discussions with the Global Resource for Advancing Cancer Education
In this podcast series, the Global Resource for Advancing Cancer Education (GRACE) works to bring professionals together with patients and caregivers to work in partnership. We interview patients, advocates and healthcare professionals to provide the most updated information for our community and to highlight important issues facing those dealing with a cancer diagnosis. For more information visit www.cancerGRACE.org. To join the conversation, visit https://cancergrace.org/forums
Where to listen?
Podcasts in the app Replaio Radio Coming soonPodcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts
Install for free
Android 5M+ downloads · 4.8 rating
iOS soon
Episodes
The Importance of Biomarker Testing: What is Liquid Biopsy? 16.11.2023 4:55
Dr. Aakash Desai details the importance of biomarker testing, and discusses the method of liquid biopsy to do so.
Barriers to Biomarker Testing: Cost and Insurance 10.11.2023 3:30
Dr. Aakash Desai discusses how to address the issues of cost and insurance approval when obtaining biomarker testing.
Neoadjuvant Treatment for Patients with NSCLC 27.10.2023 3:11
Dr. Joshua Reuss examines data on neoadjuvant targeted therapy.
The Alina Trial for ALK+ NSCLC 21.10.2023 1:13
Dr. Joshua Reuss gives a brief description of the ongoing Alina trial for patients with ALK+ NSCLC.
Local Therapy for Limited Metastatic NSCLC 17.10.2023 4:17
Dr. Puneeth Iyengar discusses the concept of using local therapy as an additional treatment for limited metastatic NSCLC, including Stereotactic Body Radiation Therapy (SBRT).
Immunotherapy for Patients with Resectable NSCLC and a Driver Mutation 10.10.2023 2:05
Dr. Joshua Reuss explains why immunotherapy is not typically given to patients with resectable NSCLC and a driver mutation.
Treatment Options for Patients with Locally Advanced Unresectable NSCLC 03.10.2023 1:59
Dr. Joshua Reuss discusses treatment options for patients with locally advanced NSCLC, and how to proceed while waiting for trial data.
Local Therapy for NSCLC Patients After Frontline Therapy 27.09.2023 7:52
Dr. Puneeth Iyengar discusses local therapy options for patients with metastatic disease who have received a front line therapy.
The Role of the Patient as Advocate 24.09.2023 2:59
Dr. Joshua Reuss discusses what the patient can do to advocate for themselves during treatment.
Targeted Therapy Before Surgery in Patients with Resectable NSCLC and Driver Mutation 20.09.2023 3:12
Dr. Joshua Reuss discusses considerations and questions for targeted therapy before surgery.
Local Therapy for Patients with Oligoprogressive NSCLC 15.09.2023 5:27
Dr. Puneeth Iyengar discusses local therapy treatment options for patients who have oligoprogressive disease.
The Future of Local Therapy in Lung Cancer 14.09.2023 2:55
Dr. Puneeth Iyengar examines what has been learned from studies, what still remains unanswered, and future directions of local therapy treatments for patients with NSCLC.
Adding to Targeted Therapy: Current Statistics and Biology 14.09.2023 5:17
Dr. Puneeth Iyengar looks at current statistics for methods of adding to targeted therapy, as well as giving an overview of biology in treatment.
The Importance of Prostate Cancer Screening 01.09.2023 3:45
Dr. Rana McKay discusses why it's crucial to get a prostate cancer screening.
सामान्य परामर्श मुद्दे (Common Consultation Issues) 30.08.2023 3:52
डॉ. अलंकृता तनेजा ट्रांसजेंडर मरीजों में देखे जाने वाले सामान्य परामर्श मुद्दों पर चर्चा करती हैं, और सही मॉनिटरिंग का महत्व बताती हैं। (Dr. Alankrita Taneja discusses common consultation issues seen in transgender patients, and the importance of proper monitoring.)
पुरुषत्वीकरण चिकित्सा और द्वितीय एरिथ्रोसाइटोसिस (Masculinizing Therapy and Secondary Erythrocytosis) 23.08.2023 8:01
डॉ. अलंकृता तनेजा टेस्टोस्टेरोन थेरेपी और इसके साथ आने वाले जोखिमों पर चर्चा करती हैं, जिसमें द्वितीय एरिथ्रोसाइटोसिस भी शामिल है। (Dr. Alankrita Taneja discusses testosterone therapy and the risks that come with it, including secondary erythrocytosis.)
सिकल सेल रोग और जेंडर अफर्मिंग हार्मोन थेरेपी (Sickle Cell Disease and Gender Affirming Hormone Therapy) 16.08.2023 3:09
डॉ. अलंकृता तनेजा सिकल सेल रोग वाले लोगों के लिए उपचार विकल्पों की जांच करती हैं, जो जेंडर अफर्मिंग हार्मोन थेरेपी के अधीन हैं। (Dr. Alankrita Taneja examines the treatment options for people with Sickle Cell Disease who are undergoing gender affirming hormone therapy.)
फेमिनाइजिंग थेरेपी और थ्रोम्बोसिस (Feminizing Therapy and Thrombosis) 09.08.2023 9:37
डॉ. अलंकृता तनेजा एस्ट्रोजन थेरेपी और इसके संभावित दुष्प्रभावों की जांच करती हैं। (Dr. Alankrita Taneja examines estrogen therapy and its potential side effects.)
भारत में ट्रांसजेंडर मुद्दे (Transgender Issues in India) 04.08.2023 3:05
डॉ. अलंकृता तनेजा भारत में ट्रांसजेंडर लोगों के संबंधित शब्दावली और सामाजिक मुद्दों का एक संक्षिप्त विवरण देती है। (Dr. Alankrita Taneja gives a brief description of terminology and social issues surrounding transgender people in India.)
Neoadjuvant Therapy in Melanoma: Does It Give a Better Immune Response? 07.06.2023 5:36
Dr. Vernon Sondak makes the argument that neoadjuvant therapy leads to a better immune response in patients with melanoma.
Neoadjuvant Therapy for Melanoma 02.06.2023 7:26
Dr. Vernon Sondak discusses the pros and cons of neoadjuvant therapy, or receiving treatment before surgery.
Adjuvant Therapy for Melanoma 29.05.2023 3:14
Dr. Vernon Sondak discusses the pros and cons of adjuvant therapy, or receiving treatment after surgery.
Adjuvant Therapy in Stage 3 and 4 Melanoma 26.05.2023 5:42
Dr. Meredith McKean discusses recent findings in adjuvant therapy for patients with stage 3 or 4 melanoma.
Patient Selection for First Line Therapy in Stage 4 Melanoma 22.05.2023 6:00
Dr. Vernon Sondak discusses current patient treatment standards, including using immune therapy before targeted therapy in unresectable stage 4 disease.
Neoadjuvant Therapy in Melanoma: The PRADO Trial 19.05.2023 3:48
Dr. Vernon Sondak examines the PRADO trial and what it means for drug regimens moving forward.
Similar podcasts
Listen to the GRACEcast - Discussions with the Global Resource for Advancing Cancer Education podcast in Replaio
Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch
Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.
